Michael B. Hoffman Insider Profile
18 Followers
Michael B. Hoffman, Chairman and CEO, Director at Translational Development Acquisition Corp., holds ― shares in Translational Development Acquisition Corp. (Ticker: TDAC), holds 3.59M shares in Annovis Bio (Ticker: ANVS), holds 22.48K shares in Traws Pharma (Ticker: TRAW). Most recently, Michael B. Hoffman ― shares of Translational Development Acquisition Corp. on ― for an estimated value of ―.
Michael B. Hoffman Translational Development Acquisition Corp. (TDAC)Chairman and CEO, Director
Translational Development Acquisition Corp. (TDAC)
Chairman and CEO, Director
Ranked #52,568 out of 108,328 Corporate Insiders
Profitable Transactions
3 out of 13 Profitable Transactions
Average Return
+0.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael B. Hoffman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael B. Hoffman
Michael B. Hoffman's Trading History
Translational Development Acquisition Corp.
―
Chairman and CEO, Director
―
―
Traws Pharma
Aug 31, 2020
Director
Informative Sell
49.78K
$10.12K
Annovis Bio
May 21, 2026
Director
Informative Buy
142.24K
$6.28M
Enviva
―
―
―
$0.00
Buckeye Partners
―
―
―
$0.00
Pattern Energy
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Michael B. Hoffman's performance on stock
You May Also Like
Michael B. Hoffman insider profile FAQ
What is the percentage of profitable transactions made by Michael B. Hoffman?
The percentage of profitable transactions made by Michael B. Hoffman is 23%.
What is the average return per transaction made by Michael B. Hoffman?
The average return per transaction made by Michael B. Hoffman is 0.10%.
What stocks does Michael B. Hoffman hold?
Michael B. Hoffman holds: TDAC, TRAW, ANVS, EVVAQ, BPL, PEGI stocks.
What was Michael B. Hoffman’s latest transaction?
Michael B. Hoffman latest transaction was an Uninformative Buy of ―.
What was Michael B. Hoffman's most profitable transaction?
Michael B. Hoffman’s most profitable transaction was an Informative Buy of ANVS stock on February 5, 2020. The return on the trade was 181.70%.
What is Michael B. Hoffman's role in Translational Development Acquisition Corp.?
Michael B. Hoffman's role in Translational Development Acquisition Corp. is Chairman and CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.